{
    "nct_id": "NCT03252847",
    "official_title": "An Open Label, Multi-centre, Phase I/II Dose Escalation Trial of a Recombinant Adeno-associated Virus Vector (AAV2/5-hRKp.RPGR) for Gene Therapy of Adults and Children With X-linked Retinitis Pigmentosa Owing to Defects in Retinitis Pigmentosa GTPase Regulator (RPGR)",
    "inclusion_criteria": "Key inclusion Criteria:\n\n* Males aged 5 years or older\n* Have X-linked retinitis pigmentosa confirmed by a retinal specialist (CI or PI)\n\nKey exclusion Criteria:\n\nâ€¢ Have participated in another research study involving an investigational medicinal therapy for ocular disease within the last 6 months\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 5 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}